Importance of biologics in rheumatoid arthritis management

Simple item page
dc.contributor.advisorHaque, Md. Aminul
dc.contributor.authorRiyadh, S. M.
dc.date.accessioned2022-04-04T03:30:48Z
dc.date.available2022-04-04T03:30:48Z
dc.date.issued2021-12
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 27-33).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
dc.description.abstractRheumatoid arthritis (RA) is an autoimmune condition that causes chronic joint inflammation pain, eventually leading to significant bone and cartilage damage in the affected joint. Around the world, RA affects a large number of people in their later years. The most frequent joints affected by RA are the elbow, shoulder and metacarpophalangeal joints. Conventional medication previously only treated the symptoms of RA. To treat the etiology of RA, biological disease modifying anti-rheumatic medicines (bDMARDs) target biological receptors such as TNF-alpha, IL-1 and IL-6. This review article discusses the benefits of using biological disease modifiers.
dc.identifier.otherID 17146009
dc.identifier.otherhttps://dspace.bracu.ac.bd/server/api/core/items/b74b30f1-1c43-4a19-8d2f-bbac86152d34
dc.identifier.urihttp://hdl.handle.net/10361/16507
dc.language.isoen
dc.publisherBRAC University
dc.sourceBRAC University Institutional Repository
dc.subjectRheumatoid arthritis
dc.subjectTNF-alpha
dc.subjectInterleukin
dc.subjectDisease-modifying anti rheumatic drugs
dc.subjectBiological disease-modifying anti rheumatic drugs
dc.titleImportance of biologics in rheumatoid arthritis management
dc.typeThesis

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
17146009_PHR.pdf
Size:
1.79 MB
Format:
Adobe Portable Document Format
Download

Collections

Project report & Thesis (Bachelor of Pharmacy)